Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

Marshall Pillay joins OKRA

   656
Marshall Pillay joins OKRA

Cambridge, UK, October 5th 2020 - OKRA is thrilled to announce the appointment of Marshall Pillay as VP Commercial - Europe and International. Starting today, Marshall will join OKRA from AKTANA, where he was most recently GM of Europe, responsible for all business and operations in the continent.

OKRA raises ambitious target to 6 million predictions in Life Sciences by end of 2020

   606
OKRA raises ambitious target to 6 million predictions in Life Sciences by end of 2020

Cambridge, UK, September 29th 2020 - Following on from June's breakthrough news that OKRA hit its target of 2 million validated predictions at >95% accuracy a full 6 months early, the company has set its sights on a record-breaking 6 million predictions completed by year end. This means that pharma companies have benefitted from an unparalleled level of support during the most uncertain time in recent memory, using predictions to guide their staff to take the right next step. This is 1 million more than the revised target set only in June.

OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

   770
OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

Cambridge, UK, 19 June 2020 - OKRA, a leading provider of Artificial Intelligence (AI) driven analytics for Life Sciences, today hit an important milestone, delivering 2 million validated predictions so far in 2020, smashing through its yearly target in just half the expected time. This underscores OKRA’s achievements in empowering the pharmaceutical industry with explainable, real-time AI solutions.

SHARE